A detailed history of John G Ullman & Associates Inc transactions in Baxter International Inc stock. As of the latest transaction made, John G Ullman & Associates Inc holds 63,107 shares of BAX stock, worth $2.07 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
63,107
Previous 54,207 16.42%
Holding current value
$2.07 Million
Previous $2.1 Million 28.74%
% of portfolio
0.43%
Previous 0.34%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$37.88 - $43.77 $337,132 - $389,553
8,900 Added 16.42%
63,107 $2.7 Million
Q4 2023

Jan 31, 2024

SELL
$31.71 - $38.95 $495,373 - $608,476
-15,622 Reduced 22.37%
54,207 $2.1 Million
Q3 2023

Nov 01, 2023

SELL
$37.32 - $49.29 $119,013 - $157,185
-3,189 Reduced 4.37%
69,829 $2.64 Million
Q2 2023

Aug 21, 2023

BUY
$39.98 - $47.68 $393,163 - $468,885
9,834 Added 15.56%
73,018 $3.33 Million
Q1 2023

May 05, 2023

BUY
$37.58 - $52.57 $1.35 Million - $1.89 Million
36,000 Added 132.43%
63,184 $2.56 Million
Q4 2022

Feb 08, 2023

SELL
$49.7 - $57.71 $1.97 Million - $2.28 Million
-39,550 Reduced 59.27%
27,184 $1.39 Million
Q3 2022

Oct 19, 2022

BUY
$53.86 - $66.8 $89,246 - $110,687
1,657 Added 2.55%
66,734 $3.59 Million
Q2 2022

Jul 27, 2022

BUY
$63.83 - $80.0 $2.57 Million - $3.22 Million
40,278 Added 162.42%
65,077 $4.18 Million
Q1 2022

Apr 29, 2022

SELL
$76.85 - $89.45 $9,836 - $11,449
-128 Reduced 0.51%
24,799 $1.92 Million
Q4 2021

Jan 26, 2022

BUY
$74.57 - $87.19 $242,352 - $283,367
3,250 Added 14.99%
24,927 $2.14 Million
Q3 2021

Nov 02, 2021

BUY
$73.77 - $83.61 $521,332 - $590,871
7,067 Added 48.37%
21,677 $1.74 Million
Q2 2021

Jul 23, 2021

SELL
$80.5 - $88.01 $28,738 - $31,419
-357 Reduced 2.39%
14,610 $1.18 Million
Q1 2021

Apr 22, 2021

SELL
$76.38 - $86.03 $15,276 - $17,206
-200 Reduced 1.32%
14,967 $1.26 Million
Q4 2020

Feb 05, 2021

SELL
$75.39 - $82.36 $30,005 - $32,779
-398 Reduced 2.56%
15,167 $1.22 Million
Q3 2020

Nov 06, 2020

SELL
$78.33 - $90.73 $23,499 - $27,219
-300 Reduced 1.89%
15,565 $1.25 Million
Q1 2020

Apr 14, 2020

SELL
$71.57 - $93.3 $347,901 - $453,531
-4,861 Reduced 23.45%
15,865 $1.29 Million
Q4 2019

Jan 29, 2020

SELL
$76.7 - $88.45 $65,195 - $75,182
-850 Reduced 3.94%
20,726 $1.73 Million
Q3 2019

Oct 21, 2019

SELL
$81.4 - $89.78 $2.76 Million - $3.04 Million
-33,850 Reduced 61.07%
21,576 $1.89 Million
Q2 2019

Aug 02, 2019

SELL
$73.44 - $82.41 $22,032 - $24,723
-300 Reduced 0.54%
55,426 $4.54 Million
Q1 2019

Apr 30, 2019

SELL
$64.48 - $81.31 $52,099 - $65,698
-808 Reduced 1.43%
55,726 $4.53 Million
Q4 2018

Jan 29, 2019

SELL
$61.45 - $77.8 $76,013 - $96,238
-1,237 Reduced 2.14%
56,534 $3.72 Million
Q3 2018

Nov 02, 2018

SELL
$70.71 - $77.75 $14,141 - $15,550
-200 Reduced 0.35%
57,771 $4.45 Million
Q2 2018

Jul 23, 2018

SELL
$63.43 - $75.41 $210,714 - $250,512
-3,322 Reduced 5.42%
57,971 $4.28 Million
Q1 2018

Apr 19, 2018

SELL
$62.56 - $72.26 $956,167 - $1.1 Million
-15,284 Reduced 19.96%
61,293 $3.99 Million
Q4 2017

Jan 31, 2018

SELL
$61.45 - $66.05 $1.38 Million - $1.48 Million
-22,431 Reduced 22.66%
76,577 $4.95 Million
Q3 2017

Nov 03, 2017

BUY
$59.5 - $64.61 $5.89 Million - $6.4 Million
99,008
99,008 $6.21 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.6B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track John G Ullman & Associates Inc Portfolio

Follow John G Ullman & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of John G Ullman & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on John G Ullman & Associates Inc with notifications on news.